UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.499

Sortiert nach

Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologist

Netherlands heart journal, 2019-09, Vol.27 (9), p.403-413

2019

Volltextzugriff (PDF)

Potential survival gains in the treatment of myocardial infarction

Heart (British Cardiac Society), 2009-11, Vol.95 (22), p.1844-1850

2009

Volltextzugriff (PDF)

Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: The SOURCE ANZ registry: Outcomes at 30 days and one year

International journal of cardiology, 2014-01, Vol.170 (3), p.406-412

2014

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

European heart journal, 2002-09, Vol.23 (18), p.1441-1448

2002

Volltextzugriff (PDF)

Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes

Heart (British Cardiac Society), 2010-08, Vol.96 (15), p.1201-1206

2010

Volltextzugriff (PDF)

Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes

Heart (British Cardiac Society), 2009-09, Vol.95 (17), p.1442-1448

2009

Volltextzugriff (PDF)

Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective

International journal of cardiology, 2022-02, Vol.349, p.96-98

2022

Volltextzugriff (PDF)

Unperceived treatment gaps in acute coronary syndromes

International journal of clinical practice (Esher), 2009-10, Vol.63 (10), p.1456-1464

2009

Volltextzugriff (PDF)

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

Heart (British Cardiac Society), 2006-07, Vol.92 (7), p.945-950

2006

Volltextzugriff (PDF)

Morbidity, mortality and economic burden of renal impairment in cardiac intensive care

Internal medicine journal, 2006-03, Vol.36 (3), p.185-192

2006

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Circulation (New York, N.Y.), 2001-12, Vol.104 (23), p.2767-2771

2001

Volltextzugriff (PDF)

Relation of inflammation and benefit of statins after percutaneous coronary interventions

Circulation (New York, N.Y.), 2003-04, Vol.107 (13), p.1750-1756

2003

Volltextzugriff (PDF)

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists : A meta-analysis of phase III multicenter randomized trials

Circulation (New York, N.Y.), 2001-01, Vol.103 (2), p.201-206

2001

Volltextzugriff (PDF)

Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again?

Internal medicine journal, 2016-02, Vol.46 (2), p.158-166

2016

Volltextzugriff (PDF)

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

Circulation (New York, N.Y.), 2001-01, Vol.103 (3), p.363-368

2001

Volltextzugriff (PDF)

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

Circulation (New York, N.Y.), 2001-08, Vol.104 (9), p.992-997

2001

Volltextzugriff (PDF)

Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit

Internal medicine journal, 2007-11, Vol.37 (11), p.741-748

2007

Volltextzugriff (PDF)

Impact of age, gender and indigenous status on access to diagnostic coronary angiography for patients presenting with non-ST segment elevation acute coronary syndromes in Australia

Internal medicine journal, 2013-03, Vol.43 (3), p.317-322

2013

Volltextzugriff (PDF)

An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease

Internal medicine journal, 2011-10, Vol.41 (10), p.743-750

2011

Volltextzugriff (PDF)

Defining the optimal activated clotting time during percutaneous coronary intervention : Aggregate results from 6 randomized, controlled trials

Circulation (New York, N.Y.), 2001-02, Vol.103 (7), p.961-966

2001

Volltextzugriff (PDF)

Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials

Internal medicine journal, 2002-07, Vol.32 (7), p.338-345

2002

Volltextzugriff (PDF)

Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

The American journal of cardiology, 2001-09, Vol.88 (6), p.672-674

2001

Volltextzugriff (PDF)

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea

The New England journal of medicine, 2016-09, Vol.375 (10), p.919-931

2016

Volltextzugriff (PDF)

Patterns of inflammatory activation associated with precipitants of acute coronary syndromes: a case-crossover study

Internal medicine journal, 2012-10, Vol.42 (10), p.1096-1103

2012

Volltextzugriff (PDF)

GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us

Cleveland Clinic journal of medicine, 2001-12, Vol.68 (12), p.1017-1023

2001

Volltextzugriff (PDF)

1 – 25 von 1.499

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.067)
Mit Volltextzugriff
(1.323)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.146)
Life Sciences & Biomedicine
(669)
Humans
(540)
Physical Sciences
(416)
Physics
(363)
Male
(361)
Female
(353)
Physics, Particles & Fields
(322)
Biological And Medical Sciences
(257)
Middle Aged
(231)
Medical Sciences
(207)
Aged
(185)
Animals
(165)
Adult
(156)
Technology
(119)
Cardiovascular System & Cardiology
(104)
Particle Beams
(103)
Cardiac & Cardiovascular Systems
(98)
Radio Frequency
(83)
Risk Factors
(83)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Artificial intelligence in cardiovascular imaging: state of the art and implications for the imaging cardiologist

Potential survival gains in the treatment of myocardial infarction

Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: The SOURCE ANZ registry: Outcomes at 30 days and one year

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes

Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes

Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective

Unperceived treatment gaps in acute coronary syndromes

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

Morbidity, mortality and economic burden of renal impairment in cardiac intensive care

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Relation of inflammation and benefit of statins after percutaneous coronary interventions

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists : A meta-analysis of phase III multicenter randomized trials

Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again?

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit

Impact of age, gender and indigenous status on access to diagnostic coronary angiography for patients presenting with non-ST segment elevation acute coronary syndromes in Australia

An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease

Defining the optimal activated clotting time during percutaneous coronary intervention : Aggregate results from 6 randomized, controlled trials

Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials

Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea

Patterns of inflammatory activation associated with precipitants of acute coronary syndromes: a case-crossover study

GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us

Suchergebnisse filtern